Pharma Mar | PHM - Ebit

Stock Price
96.30
Daily Change
-1.30 -1.33%
Monthly
-1.23%
Yearly
22.68%
Q2 Forecast
93.78

Pharma Mar reported EUR622K in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Almirall EUR 30.23M 12.8M Dec/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Ionis Pharmaceuticals USD -118M 97M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Moderna USD -1.39B 531M Mar/2026
Organon & Co USD -27M 415M Dec/2025
Pharma Mar EUR 622K 42.99M Mar/2026
Revvity USD 82.77M 63.06M Mar/2026
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Viatris USD -20.2M 137.3M Mar/2026
Xeris Pharmaceuticals USD 16.77M 8.88M Dec/2025